June 1 (Reuters) - Sirtex Medical Ltd SRX.AX :
* Says "set revised full year dose sales growth guidance at 15-17% compared to
the pcp versus previous guidance"
* Source text for Eikon ID:nASX6SB7Ld
June 1 (Reuters) - Sirtex Medical Ltd SRX.AX :
* Says "set revised full year dose sales growth guidance at 15-17% compared to
the pcp versus previous guidance"
* Source text for Eikon ID:nASX6SB7Ld